Mixed chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

被引：0
|
作者：
de Lima, M [1 ]
Carrasco, A [1 ]
Lee, MS [1 ]
Saliba, R [1 ]
Glassman, A [1 ]
Anagnostopoulos, A [1 ]
Couriel, D [1 ]
Caldera, H [1 ]
Andersson, BS [1 ]
El-Zimaity, M [1 ]
Giralt, S [1 ]
Champlin, R [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2616
引用
收藏
页码：707A / 707A
页数：1
相关论文
共 50 条
  • [41] Allogeneic hematopoietic stem cell transplant (HSCT) in adults with acute myeloid leukemia (AML) - A single program experience
    Obenchain, R
    Ruffner, K
    Stokes, D
    Wu, W
    Brandt, S
    Chinratanalab, W
    Jagasia, M
    Kassim, A
    Greer, J
    Morgan, D
    Stein, R
    Vusirikala, M
    Schuening, F
    Goodman, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 88 - 88
  • [42] Radiolabeled anti-CD45 antibody with cyclophosphamide (CY) and total body irradiation (TBI) followed by allogeneic hematopoietic stem cell transplantation (HSCT) for patients with advanced acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Rosario, E
    Rajendran, J
    Ruffner, KL
    Eary, JF
    Fisher, DR
    Appelbaum, FR
    Bernstein, ID
    Matthews, DC
    BLOOD, 2001, 98 (11) : 857A - 857A
  • [43] Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome
    Jennifer H. Cooperrider
    Noreen Fulton
    Andrew S. Artz
    Richard A. Larson
    Wendy Stock
    Satyajit Kosuri
    Michael Bishop
    Hongtao Liu
    Bone Marrow Transplantation, 2020, 55 : 2204 - 2206
  • [44] Personalized Circulating Tumor DNA Predicts Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Nakamura, Sousuke
    Yokoyama, Kazuaki
    Yusa, Nozomi
    Ogawa, Miho
    Takei, Tomomi
    Kobayashi, Asako
    Ito, Mika
    Kobayashi, Masayuki
    Jimbo, Koji
    Tanoue, Susumu
    Isobe, Masamichi
    Konuma, Takaaki
    Kato, Seiko
    Shimizu, Eigo
    Kasajima, Rika
    Wada, Yuka
    Yamaguchi, Rui
    Imoto, Seiya
    Furukawa, Yoichi
    Nagamura-Inoue, Tokiko
    Takahashi, Satoshi
    Miyano, Satoru
    Tojo, Arinobu
    BLOOD, 2017, 130
  • [45] Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome
    Cooperrider, Jennifer H.
    Fulton, Noreen
    Artz, Andrew S.
    Larson, Richard A.
    Stock, Wendy
    Kosuri, Satyajit
    Bishop, Michael
    Liu, Hongtao
    BONE MARROW TRANSPLANTATION, 2020, 55 (11) : 2204 - 2206
  • [46] Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
    Chien, Sheng-Hsuan
    Yao, Ming
    Li, Chi-Cheng
    Chang, Ping-Ying
    Yu, Ming-Sun
    Huang, Cih-En
    Tan, Tran-Der
    Lin, Cheng-Hsien
    Yeh, Su-Peng
    Li, Sin-Syue
    Wang, Po-Nan
    Liu, Yi-Chang
    Gau, Jyh-Pyng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (12) : 2144 - 2152
  • [47] ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR SECONDARY ACUTE MYELOID LEUKEMIA EVOLVING FROM MYELODYSPLASTIC SYNDROME
    Park, Y. -H
    Lee, J-H
    Lee, K-H
    Kim, D. -Y
    Kim, S. -D
    Choi, Y.
    Seol, M.
    Lee, Y-S
    Kong, Y-A
    Jeon, M.
    Lee, J-H
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S331 - S331
  • [48] Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation
    J Mattsson
    M Uzunel
    L Tammik
    J Aschan
    O Ringdén
    Leukemia, 2001, 15 : 1976 - 1985
  • [49] Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation
    Mattsson, J
    Uzunel, M
    Tammik, L
    Aschan, J
    Ringden, O
    BONE MARROW TRANSPLANTATION, 2001, 27 : S29 - S29
  • [50] Low-Dose Azacitidine (AZA) for Treatment of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapse after Allogeneic Hematopoietic Cell Transplant (HCT)
    Ueda, Masumi
    Lazarus, Hillard M.
    Cooper, Brenda
    Caimi, Paolo
    Creger, Richard
    Little, Jane A.
    Baer, Linda
    Brister, Lauren
    Malek, Ehsan
    Metheny, Leland, III
    Tomlinson, Benjamin
    Gerson, Stan L.
    Oran, Betul
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S212 - S213
12345